Shares of Sanofi (NYSE:SNY) gapped up prior to trading on Friday . The stock had previously closed at $37.91, but opened at $38.41. Sanofi shares last traded at $39.16, with a volume of 754,046 shares changing hands.

Several analysts have recently issued reports on the company. TheStreet downgraded Sanofi from a “buy” rating to a “hold” rating in a research report on Monday, August 22nd. Berenberg Bank restated a “hold” rating and issued a $93.00 price objective on shares of Sanofi in a research report on Monday, August 15th. Zacks Investment Research downgraded Sanofi from a “hold” rating to a “sell” rating in a research report on Wednesday, August 3rd. Citigroup Inc. restated a “neutral” rating on shares of Sanofi in a research report on Tuesday, June 28th. Finally, Barclays PLC upgraded Sanofi from an “equal weight” rating to an “overweight” rating in a research report on Thursday, May 12th. Four equities research analysts have rated the stock with a sell rating, seven have given a hold rating and four have given a buy rating to the company. The company currently has a consensus rating of “Hold” and a consensus target price of $60.50.

The company has a 50-day moving average price of $40.45 and a 200-day moving average price of $40.65. The stock has a market cap of $100.85 billion and a P/E ratio of 21.64.

Sanofi SA is a healthcare company focused on patient needs and engaged in the research, development, manufacture and marketing of healthcare products. The Company is organized around three principal activities: Pharmaceuticals, Human Vaccines via Sanofi Pasteur, and Animal Health via Merial. The Company invests in emerging markets, diabetes solutions, vaccines, consumer health care, animal health, genzyme and other products.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.